New York City, NY – According to filings with the U.S. Securities and Exchange Commission, PAVmed is raising $7,750,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Lishan Aklog played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About PAVmed

PAVmed Inc. (Nasdaq:PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation.

To learn more about PAVmed, visit http://www.pavmed.com/

Contact:
Lishan Aklog, Chief Executive Officer
212-949-4319
lishan@pavmed.com
https://www.linkedin.com/in/laklog/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved